Semaglutide (sold as Wegovy for weight loss, Ozempic for diabetes) and tirzepatide (Zepbound for weight loss, Mounjaro for diabetes) are the most prescribed
adults have obesity, defined by a body mass index (BMI) of 30 or higher
Bachem, Biosynth, Phoenix Pharmaceuticals, CPC Scientific, and similar businesses matter in the peptide industry, but they are not the same type of company as research peptide storefronts
Scientific References Wegovy 2.4 mg, FlexTouch solution for injection in pre-filled pen Summary of Product Characteristics (SmPC)
According to CATDH, there are currently no obesity or weight loss medications on the Canadian market that will be reimbursed by the provincial or federal government
Vomiting occurred in 24.5 percent of semaglutide users versus 6.3 percent on placebo